A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 245,300 shares of ORMP stock, worth $583,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares
245,300
Previous 230,800 6.28%
Holding current value
$583,814
Previous $593,000 0.84%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.21 - $2.63 $32,045 - $38,135
14,500 Added 6.28%
245,300 $598,000
Q2 2024

Aug 09, 2024

BUY
$2.07 - $2.83 $225,008 - $307,621
108,700 Added 89.03%
230,800 $593,000
Q1 2024

May 13, 2024

SELL
$2.18 - $3.58 $477,361 - $783,923
-218,973 Reduced 64.2%
122,100 $357,000
Q4 2023

Feb 13, 2024

BUY
$1.71 - $2.57 $507,481 - $762,706
296,773 Added 669.92%
341,073 $788,000
Q3 2023

Nov 14, 2023

BUY
$2.51 - $3.55 $26,605 - $37,630
10,600 Added 31.45%
44,300 $116,000
Q2 2023

Aug 11, 2023

BUY
$2.12 - $4.47 $46,216 - $97,446
21,800 Added 183.19%
33,700 $121,000
Q1 2023

May 12, 2023

BUY
$1.93 - $13.1 $22,967 - $155,890
11,900 New
11,900 $26,000
Q2 2022

Aug 12, 2022

BUY
$3.72 - $9.0 $1.34 Million - $3.24 Million
359,697 New
359,697 $1.65 Million
Q1 2022

May 13, 2022

SELL
$8.19 - $13.89 $1.66 Million - $2.82 Million
-203,200 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$12.98 - $29.75 $2.64 Million - $6.05 Million
203,200 New
203,200 $2.9 Million
Q1 2021

May 13, 2021

SELL
$4.22 - $11.33 $1.57 Million - $4.22 Million
-372,415 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$2.48 - $4.64 $238,576 - $446,367
-96,200 Reduced 20.53%
372,415 $1.58 Million
Q3 2020

Nov 13, 2020

BUY
$2.58 - $4.16 $630,294 - $1.02 Million
244,300 Added 108.91%
468,615 $1.22 Million
Q2 2020

Aug 13, 2020

BUY
$2.87 - $4.12 $103,033 - $147,908
35,900 Added 19.05%
224,315 $792,000
Q1 2020

May 14, 2020

SELL
$2.6 - $5.5 $102,206 - $216,205
-39,310 Reduced 17.26%
188,415 $573,000
Q4 2019

Feb 13, 2020

BUY
$2.43 - $5.74 $38,394 - $90,692
15,800 Added 7.46%
227,725 $1.17 Million
Q3 2019

Nov 13, 2019

BUY
$2.88 - $3.96 $155,021 - $213,154
53,827 Added 34.05%
211,925 $676,000
Q2 2019

Aug 12, 2019

BUY
$2.88 - $4.36 $152,763 - $231,267
53,043 Added 50.49%
158,098 $568,000
Q1 2019

May 14, 2019

BUY
$2.95 - $3.64 $137,254 - $169,358
46,527 Added 79.5%
105,055 $382,000
Q4 2018

Feb 13, 2019

BUY
$3.0 - $4.94 $175,584 - $289,128
58,528 New
58,528 $176,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92.4M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.